13F Data
13F filer · CIK 1645157

Foresite Capital Management III, LLC

Larkspur, CA · filing since Q4 2015 · last filing Nov 14, 2022
Reported value
$37.9M
+$10.3M vs prior
Positions
4
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q2 2022

No new or increased positions this quarter.

Biggest sells vs Q2 2022

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $112.8MQ1 2016: $129.2MQ2 2016: $145.7MQ3 2016: $213.9MQ4 2016: $230.1MQ1 2017: $260.5MQ2 2017: $306.1MQ3 2017: $363.1MQ4 2017: $356.3MQ1 2018: $458.8MQ2 2018: $464.4MQ3 2018: $453.2MQ4 2018: $304.5MQ1 2019: $384.2MQ2 2019: $304.9MQ3 2019: $261.9MQ4 2019: $178.4MQ1 2020: $62.8MQ2 2020: $112.5MQ3 2020: $134.3MQ4 2020: $86.0MQ1 2021: $113.9MQ2 2021: $94.3MQ3 2021: $72.1MQ4 2021: $39.5MQ1 2022: $32.8MQ2 2022: $27.6MQ3 2022: $37.9M
Q4 2015Q3 2022

Holdings · Q3 2022

#SecuritySharesValueWeight
1Ascendis Pharma A/SSPONSORED ADS133,691$13.8M36.44%
2Verona Pharma PLC.SPONSORED ADS1,111,112$11.4M29.98%
3Natera, Inc.COM159,160$7.0M18.41%
4Cymabay Therapeutics, Inc.COM1,641,804$5.7M15.17%